These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 19409858)

  • 1. A randomized, double-blind, placebo-controlled trial of a selective COX-2 inhibitor, GW406381, in patients with postherpetic neuralgia.
    Shackelford S; Rauck R; Quessy S; Blum D; Hodge R; Philipson R
    J Pain; 2009 Jun; 10(6):654-60. PubMed ID: 19409858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized, controlled, dose-ranging study investigating single doses of GW406381, naproxen sodium, or placebo in patients with acute pain after third molar tooth extraction.
    Varner J; Lomax M; Blum D; Quessy S
    Clin J Pain; 2009 Sep; 25(7):577-83. PubMed ID: 19692798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, randomized, placebo-controlled, single-dose study of the cyclooxygenase-2 inhibitor, GW406381, as a treatment for acute migraine.
    Wentz AL; Jimenez TB; Dixon RM; Aurora SK; Gold M;
    Eur J Neurol; 2008 Apr; 15(4):420-7. PubMed ID: 18312401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of gabapentin enacarbil in subjects with neuropathic pain associated with postherpetic neuralgia (PXN110748).
    Zhang L; Rainka M; Freeman R; Harden RN; Bell CF; Chen C; Graff O; Harding K; Hunter S; Kavanagh S; Laurijssens B; Schwartzbach C; Warren S; McClung C
    J Pain; 2013 Jun; 14(6):590-603. PubMed ID: 23602345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of GW406381 for treatment of osteoarthritis of the knee: two randomized, controlled studies.
    Boswell DJ; Ostergaard K; Philipson RS; Hodge RA; Blum D; Brown JC; Quessy SN
    Medscape J Med; 2008; 10(11):259. PubMed ID: 19099009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.
    Backonja M; Wallace MS; Blonsky ER; Cutler BJ; Malan P; Rauck R; Tobias J;
    Lancet Neurol; 2008 Dec; 7(12):1106-12. PubMed ID: 18977178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GW406381, a novel COX-2 inhibitor, attenuates spontaneous ectopic discharge in sural nerves of rats following chronic constriction injury.
    Zhao FY; Spanswick D; Martindale JC; Reeve AJ; Chessell IP
    Pain; 2007 Mar; 128(1-2):78-87. PubMed ID: 17055166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and efficacy of KAI-1678- an inhibitor of epsilon protein kinase C (εPKC)-versus lidocaine and placebo for the treatment of postherpetic neuralgia: a crossover study design.
    Cousins MJ; Pickthorn K; Huang S; Critchley L; Bell G
    Pain Med; 2013 Apr; 14(4):533-40. PubMed ID: 23438341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial.
    Apalla Z; Sotiriou E; Lallas A; Lazaridou E; Ioannides D
    Clin J Pain; 2013 Oct; 29(10):857-64. PubMed ID: 23370074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy and safety of celecoxib 200 mg and celecoxib 400 mg once daily in treating the signs and symptoms of psoriatic arthritis.
    Kivitz AJ; Espinoza LR; Sherrer YR; Liu-Dumaw M; West CR
    Semin Arthritis Rheum; 2007 Dec; 37(3):164-73. PubMed ID: 17570469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial.
    Schumacher HR; Berger MF; Li-Yu J; Perez-Ruiz F; Burgos-Vargas R; Li C
    J Rheumatol; 2012 Sep; 39(9):1859-66. PubMed ID: 22859357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
    Rice ASC; Dworkin RH; McCarthy TD; Anand P; Bountra C; McCloud PI; Hill J; Cutter G; Kitson G; Desem N; Raff M;
    Lancet; 2014 May; 383(9929):1637-1647. PubMed ID: 24507377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults.
    Kivitz A; Fairfax M; Sheldon EA; Xiang Q; Jones BA; Gammaitoni AR; Gould EM
    Clin Ther; 2008 Dec; 30(12):2366-77. PubMed ID: 19167595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
    Wymer JP; Simpson J; Sen D; Bongardt S;
    Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tramadol hydrochloride extended-release once-daily in the treatment of osteoarthritis of the knee and/or hip: a double-blind, randomized, dose-ranging trial.
    DeLemos BP; Xiang J; Benson C; Gana TJ; Pascual ML; Rosanna R; Fleming B
    Am J Ther; 2011 May; 18(3):216-26. PubMed ID: 20215961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind, controlled dose finding study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
    Webster LR; Malan TP; Tuchman MM; Mollen MD; Tobias JK; Vanhove GF
    J Pain; 2010 Oct; 11(10):972-82. PubMed ID: 20655809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of carisbamate in patients with diabetic neuropathy or postherpetic neuralgia: results from 3 randomized, double-blind placebo-controlled trials.
    Smith T; DiBernardo A; Shi Y; Todd MJ; Brashear HR; Ford LM
    Pain Pract; 2014 Apr; 14(4):332-42. PubMed ID: 23692321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment response in antidepressant-naïve postherpetic neuralgia patients: double-blind, randomized trial.
    Rowbotham MC; Reisner LA; Davies PS; Fields HL
    J Pain; 2005 Nov; 6(11):741-6. PubMed ID: 16275598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.